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Hereditary multiple exostoses (HME) is a skeletal disorder which primarily affects enchondral bone during growth. It is characterised by multiple exostoses, usually arising in the juxtaepiphyseal region of the long bones.
Exostoses that affect "almost every bone in the body" were first mentioned by John Hunter in his Lectures on the principles of surgery in 1786.1 The first family affected by HME was described by Boyer2 in 1814. Virchow3 named the disorder multiple exostoses in 1876, and Keith4 suggested the name diaphyseal aclasis; this term is still popular in the UK. Several other names have been used in the past and are still used today, including 'osteogenic disease', 'chondral osteogenic dysplasia', 'chondral osteoma', 'dyschondroplasia', 'deforming chondrodysplasia', 'multiple hereditary osteochondromata', 'multiple cartilaginous exostoses', or simply 'exostosis' or 'exostotic dysplasia'.
Papers that were especially important in further delineatinj the disorder were those of Jaffe,5 normally, thus obscuring the once prominent exostotic projection.6 A proven disappearance of an exostosis has not been found in any of the patients known to the present author. The characteristic radiographic appearance of exostoses may vary from broad based (sessile) (fig 2) to pedunculated. The cortex ofexostoses is continuous with that of the underlying bone. They originate in the metaphysis in long bones and migrate to the diaphysis as growth continues in the epiphysis.6 The cartilagenous cap is usually radiolucent, but after puberty irregular zones of calcification may appear. Extensive calcification with irregularities of the cap should suggest the possibility of malignant change.
I
The configuration of exostoses may be completely different, not only within different bones of a particular patient, but even within one affected bone. Exostoses prevent normal bone tubulation resulting in metaphyseal widening and growth retardation. Generally, the height of affected persons is somewhat shorter than usual (0-5 to 1-0 SD).6 9 This becomes more evident with age, especially during puberty. The sitting height averages 10 SD above height, indicating a mildly disproportionate short stature.9 Comparable findings are reported for arm span and symphyseal height. 6 The lack of height is seldom so severe that patients fall below the 3rd centile. Sometimes individual bones are more severely these patients may not suffer from HME, but from metachondromatosis,20 which is-similar to HME but differs in distribution and radiographic appearance, and in which spontaneous regression is the normal course. Another explanation may be ceasing of growth of the exostosis while the affected bone enlarges Figure 2 The most severe possible complication is malignant degeneration. In some reports about 10% of all affected persons developed an osteosarcoma.5 16 26 These figures, however, were obtained at tertiary treatment centres and are, thus, severely biased towards patients with complications. More reliable estimates point to an occurrence of malignancies in HME of 0-5 to 2%.13'5 21 Ochsner26 collected data on 59 patients with an osteosarcoma in HME. The mean age of onset of malignant degeneration is 31 years; it seldom occurs before the 10th or after the 50th year. The upper end of the femur and the pelvis are the main locations, but they may also be found in the shoulder girdle and the ribs. The first clinical signs are usually a sudden increase in size, pain, and sometimes neurological symptoms. The development is usually slow, and metastasis (lungs) is late. The therapy of choice is complete surgical removal.
Figure3 Severely affectedforearm.
Because local recurrences are frequent, the resection has to be complete. Radiation therapy has no effect.7 It seems useful to obtain radiographs of the pelvic and shoulder girdle in every young affected adult for later 26 affected. The most striking deformity may be the comparison.
shortened and bowed forearm (fig 3) . This has been reported in 7%,13 40%,5 9 50%,7 and even 60%22 of all patients. These differences in incidence may be caused by differences in definitions and groups of patients studied. Exostoses should be removed in patients when they cause disability or for cosmetic reasons, but the mere presence of an exostosis is not a reason for prophylactic excision. A complete review of therapeutic measures in HME has recently been reported by Wood et 21 The equal expression found by Solomon7 and Sugiura et al'3 may be at least partly caused by their source of patients, that is, tertiary orthopaedic clinics. Jaffe5 reported on the increase in affected offspring in the course of successive male transmissions. This may point to some influencing mechanism, for instance, imprinting.49 Anticipation was not detected. 8 13 To investigate this further, all published families were gathered in which the diagnosis was reliable, and for which full information on both affected and unaffected family members was given. These data were pooled together with our own data and analysed further (table 2). Affected fathers had more affected than unaffected offspring (99:67) while in affected mothers this ratio was about equal (79:61). This difference, however, was caused by only a few families in which a remarkable male preponderance was found'5 50 (personal observations). It seems probable thatinmostfamilies the sexdistribution is equal, but that in a minority of families some additional influence is operating. This needs further clarification.
Chromosome studies, both in horses and man,'0 51 52 and DNA polymorphism analysis in horses,53 have been inconclusive until now. Buhler and Malik54 have suggested that the mutation of HME may be sited in the region 8q23-8q24. 1, closely linked to the locus for trichorhinophalangeal syndrome (TRP) type I. They stated that TRP types I and II are possibly not separate entities, but that in TRP type II the deletion is larger and also involves the locus for HME. This theory was recently supported by the description of a patient with TRP type I and 8q deletion. 5 It is of interest to note that in TRP type II the deletion of 8q was found to be of maternal origin. 56 Restriction fragment length polymorphism analysis in man is at 
